[2012: Update on diagnosis and treatment of multiple sclerosis]

MeSH terms

• Administration, Oral
• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / adverse effects
• Brain / pathology
• Combined Modality Therapy
• Diagnosis, Differential
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Fingolimod Hydrochloride
• Glatiramer Acetate
• Glucocorticoids / administration & dosage
• Glucocorticoids / adverse effects
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects
• Infusions, Intravenous
• Interferon-beta / administration & dosage
• Interferon-beta / adverse effects
• Methylprednisolone / administration & dosage
• Methylprednisolone / adverse effects
• Mitoxantrone / administration & dosage
• Mitoxantrone / adverse effects
• Multiple Sclerosis, Chronic Progressive / diagnosis*
• Multiple Sclerosis, Chronic Progressive / drug therapy*
• Multiple Sclerosis, Relapsing-Remitting / diagnosis
• Multiple Sclerosis, Relapsing-Remitting / drug therapy*
• Natalizumab
• Peptides / administration & dosage
• Peptides / adverse effects
• Plasmapheresis
• Propylene Glycols / administration & dosage
• Propylene Glycols / adverse effects
• Pulse Therapy, Drug
• Sphingosine / administration & dosage
• Sphingosine / adverse effects
• Sphingosine / analogs & derivatives
• Spinal Cord / pathology